The United States needs more headache specialists. New, large clinical trials with diverse patient populations designed to assess the safety and efficacy of novel therapies for migraine wouldn’t hurt either.
These are just a couple of the recommendations proffered by the Society for Women’s Health Research (SWHR) in a review of current research on sex and gender differences in migraine published in the Journal of Women’s Health (2018;27[8]:965-973). The report is the result of